Expression of Bcl-2 family reduces apoptotic hepatocytes after excessive hepatectomy

Eur Surg Res. 2001;33(1):8-15. doi: 10.1159/000049686.

Abstract

Excessive hepatectomy often causes fatal hepatic failure, but the mechanism is unknown. We used a novel protocol of partial 90 and 95% hepatectomy (PHx) to investigate this mechanism in 2 groups of rats. The 90% PHx rats survived, but the 95% PHx animals died of hepatic failure. In the latter, cytokine (interleukin-6, tumor necrosis factor-alpha) levels and the apoptotic hepatocyte count increased, and there were few mitotic cells. By contrast, in the 90% PHx rats, the mitotic cell count increased, and more anti-apoptotic Bcl-xL protein was expressed. These results demonstrate that expression of Bcl-xL protein as an anti-apoptotic factor or regeneration factor contributes to survival after 90% PHx. Using an adenovirus vector, the human bcl-2 gene (hbcl-2) was therefore transfected to DA rat livers where it was efficiently expressed, and then 95% PHx was performed. Liver damage was decreased and the apoptotic cell count decreased too, but the rats died. We concluded that transfection of the hbcl-2 gene partly prevents cytotoxicity (apoptosis), but cannot ensure survival. Thus, some other factor is required (e.g., a regeneration stimulator) to maintain life in these models.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Cell Survival / physiology
  • Cytokines / blood
  • Gene Expression / physiology*
  • Genes, bcl-2 / physiology*
  • Hepatectomy / methods*
  • Hepatocytes / physiology*
  • Humans
  • Liver / pathology
  • Male
  • Postoperative Period
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Rats, Wistar
  • Survival Analysis
  • Transfection
  • bcl-X Protein

Substances

  • BCL2L1 protein, human
  • Bcl2l1 protein, rat
  • Cytokines
  • Proto-Oncogene Proteins c-bcl-2
  • bcl-X Protein